Videos / New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).
PSA Testing Demystified
Migraine Management Update
Trauma-Informed Care in GP
Prevention and Management of Diabetic Retinopathy
expert
Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland